Venkata C Sami, MD Internal Medicine - Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 5755 Cedar Ln, Columbia, MD 21044 Phone: 410-884-4644 |
Dr. Nandakumar B Vellanki, MD Internal Medicine - Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 8850 Columbia 100 Pkwy, Ste 301, Columbia, MD 21045 Phone: 301-560-4747 Fax: 301-776-1725 |
Ruth Wangui Gachao, NP Internal Medicine - Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 5978 Turnabout Ln Apt 11, Columbia, MD 21044 Phone: 918-926-0020 |
Maria Rene Munoz-ritterbusch, MD Internal Medicine - Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 8205 Snowden River Pkwy Ste 201, Columbia, MD 21045 Phone: 410-290-9990 |
News Archive
Researchers have mapped primate gene expression throughout the day and discovered that the majority of critical gene activity is time dependent, which may aid the development of new treatments for many diseases.
New evidence that homeopathic consultations can reduce the symptoms of rheumatoid arthritis has been revealed by scientists from the University of Southampton.
New research shows that more than half of women with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) have fewer children than desired. While patient choice has some influence on the smaller family size, findings published today in Arthritis Care & Research, a journal of the American College of Rheumatology (ACR), suggest that higher rates of infertility and miscarriage may also impact the number of offspring born to women with these chronic conditions.
One in every 200 Ontarians has been diagnosed with inflammatory bowel disease (IBD), with the number of people living with the disease increasing by 64 per cent between 1999 and 2008, according to a study by researchers at the Institute for Clinical Evaluative Sciences, the Children's Hospital of Eastern Ontario, and the Ottawa Hospital Research Institute.
Clinical Data, Inc. today announced that the Office of Orphan Products Development of the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for pulmonary arterial hypertension (PAH) to PRX-8066, the Company's selective serotonin 2B (5-HT2B) receptor antagonist.
› Verified 7 days ago